Big market such as China won't blindly follow FDA approvals or guide lines. They will have their own independent system to work thru.MSB would not be able to enter the Chinese market without a state owned medical partner. Having that support would be the green light to entering.Lots of ill health and money sloshing around China.Seems to me waiting for approval in USA should not prevent MSB from entering other large markets........ Unless the stem cells are not all they are made out to be.That actually seems like a more plausible explanation to me.
banter and General Discussion, page-3421
-
- There are more pages in this discussion • 6,865 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.13 | $1.09 | $4.556M | 4.141M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9590 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 3132 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |